TF and metabolic dysfunction-associated steatohepatitis: We showed that a plant-derived FGF21-transferrin fusion protein can be used for oral delivery of FGF21 as a potential therapeutic of NASH and provide an initial comparison of different production options and associated costs in transgenic seeds and leaves which both might be used for oral delivery.